These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30020422)

  • 1. Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Ard KL; Edelstein ZR; Bolduc P; Daskalakis D; Gandhi AD; Krakower DS; Myers JE; Keuroghlian AS
    Clin Infect Dis; 2019 Feb; 68(5):860-864. PubMed ID: 30020422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
    Kenison TC; Badenhop B; Safo S
    AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preexposure Prophylaxis Monitoring in New York City: A Public Health Approach.
    Myers JE; Edelstein ZR; Daskalakis DC; Gandhi AD; Misra K; Rivera AV; Salcuni PM; Scanlin K; Udeagu CC; Braunstein SL
    Am J Public Health; 2018 Nov; 108(S4):S251-S257. PubMed ID: 30383427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
    Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
    AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Demographic Characteristics of HIV Post-Exposure Prophylaxis Users in New York City.
    Adan MA; Zucker J; Carnevale C; Grant WL; Cohall AT; Gordon P; Olender SA; Sobieszczyk ME
    J Health Care Poor Underserved; 2020; 31(2):672-681. PubMed ID: 33410801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public Health Detailing to Promote HIV Pre- and Postexposure Prophylaxis Among Women's Healthcare Providers in New York City.
    Wahnich A; Gandhi AD; Cleghorn E; Estacio K; Blackstock OJ; Myers JE; Abraham B; Edelstein ZR
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S98-S107. PubMed ID: 34686296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.
    Chang HH; Kim SW; Jung H; Lee SA; Park HK; Kim S; Lee JM; Choi JY
    J Korean Med Sci; 2018 Mar; 33(12):e91. PubMed ID: 29542300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.
    Agovi AM; Anikpo I; Cvitanovich MJ; Fasanmi EO; Ojha RP; Marcus JL
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):e17-e21. PubMed ID: 34285157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
    Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
    Mullins TLK; Zimet G; Lally M; Xu J; Thornton S; Kahn JA
    AIDS Patient Care STDS; 2017 Dec; 31(12):504-516. PubMed ID: 29211514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of Pre-exposure Prophylaxis Services Across New York City Neighborhoods: Do Neighborhood Socio-demographic Characteristics and HIV Incidence Matter?
    Kim B; Callander D; DiClemente R; Trinh-Shevrin C; Thorpe LE; Duncan DT
    AIDS Behav; 2019 Oct; 23(10):2795-2802. PubMed ID: 31321639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
    Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN
    Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.
    Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA;
    Lancet HIV; 2018 Nov; 5(11):e629-e637. PubMed ID: 30343026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Among Men Who Have Sex With Men at a New England Sexually Transmitted Diseases Clinic.
    Chan PA; Glynn TR; Oldenburg CE; Montgomery MC; Robinette AE; Almonte A; Raifman J; Mena L; Patel R; Mayer KH; Beauchamps LS; Nunn AS
    Sex Transm Dis; 2016 Nov; 43(11):717-723. PubMed ID: 27893604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.
    John SA; Rendina HJ; Grov C; Parsons JT
    PLoS One; 2017; 12(12):e0189794. PubMed ID: 29281688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
    Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
    Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.